The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,401
Sort by:
North America: Vitamins Market
US$ 1,999.00
... report on the vitamins market in North America covers the following countries: Canada, Mexico, and the United States of America. The report on the vitamins market in North America includes: Analysis and ...
August 2026
150 pages
Pharmaceutical Excipients Market Size, Share and Growth Outlook 2026: By Product (Polymers, Alcohols, Sugars, Minerals, Gelatin, Lipids and Oils), By Function, By Formulation Type, Companies to 2034.
US$ 3,482.00
The global Pharmaceutical Excipients Market size is forecast to increase from $13.6 Billion in 2026 to $22.68 Billion in 2034 at a CAGR of 6.6% between 2026 and 2034. The Pharmaceutical Excipients mar...
July 2026
190 pages
Lidocaine Hydrochloride Market Size, Share and Growth Outlook 2026: By Dosage Form (Injectables, Creams, Patches, Gels, Aerosol Solutions, Other Dosage Forms), By Application, By End User, Companies to 2034.
US$ 3,482.00
The global Lidocaine Hydrochloride Market size is forecast to increase from $720.18 Million in 2026 to $1096.06 Million in 2034 at a CAGR of 5.39% between 2026 and 2034. The Lidocaine Hydrochloride ma...
July 2026
190 pages
Superdisintegrants Market Size, Share and Growth Outlook 2026: By Product (Modified Starch, Modified Cellulose, Crospovidone, Ion Exchange Resin, Natural Superdisintegrants), By Formulation, By Therapeutic Area, By End User, Companies to 2034.
US$ 3,482.00
The global Superdisintegrants Market size is forecast to increase from $619.49 Million in 2026 to $957.96 Million in 2034 at a CAGR of 5.6% between 2026 and 2034. The Superdisintegrants market report...
July 2026
190 pages
Sustained Release Excipients Market Size, Share and Growth Outlook 2026: By Product (Polymers, Gelatin, Minerals, Sugars, Alcohol, Chitosan), By Technology, By Route of Administration, By Application, Companies to 2034.
US$ 3,482.00
The global Sustained Release Excipients Market size is forecast to increase from $1.81 Billion in 2026 to $3.42 Billion in 2034 at a CAGR of 8.28% between 2026 and 2034. The Sustained Release Excipien...
July 2026
190 pages
Microbial API Market Size, Share and Growth Outlook 2026: By Type (Antibiotics, Amino Acids, Vitamins, Nucleotides, Organic Acids, Biological Products, Hormones), By Application, By Manufacturing Site, Companies to 2034.
US$ 3,482.00
The global Microbial API Market size is forecast to increase from $70.01 Billion in 2026 to $118.86 Billion in 2034 at a CAGR of 6.84% between 2026 and 2034. The Microbial API market report provides d...
July 2026
190 pages
Morphine Drugs Market Size, Share and Growth Outlook 2026: By Drug (Morphine, Buprenorphine, Noscapin, Thebaine, Etrophine), By Dosage Form, By Application, By Distribution Channel, By End-User, Companies to 2034.
US$ 3,482.00
The global Morphine Drugs Market size is forecast to increase from $26.93 Billion in 2026 to $39.4 Billion in 2034 at a CAGR of 4.87% between 2026 and 2034. The Morphine Drugs market report provides d...
July 2026
190 pages
